Picture courtesy in.news.yahoo.com
Washington: Moderna has started dosing its mRNA-1273 COVID-19 vaccine on children aged six months to less than 12 years.
“We are pleased to begin this Phase 2/3 study of mRNA-1273 on healthy children in the US and Canada and we thank NIAID and BARDA for their collaboration,” said Chief Executive Officer of Moderna Stéphane Bancel.
The trial will involve about 6,750 children in the United States and Canada. Each child will be given two shots, 28 days apart. The dosage will be lower than that for adults.
Moderna’s vaccine is being administered to people over 18 in the US.
Berhampur: Rushikulya river mouth in Odisha’s Ganjam district has emerged as a major rookery for… Read More
Delhi/Mumbai: Twin tragedies in Delhi and Mumbai claimed the lives of a pair of 18-month-old… Read More
Jajpur: A total of 894 ineligible people fraudulently received benefits under an old-age pension scheme… Read More
Bhubaneswar: The International Conference on Recent Advances in Nanomedicine brought together more than 500 participants,… Read More
New Delhi: In a recent statement that has stirred political conversations, Shashi Tharoor reaffirmed his… Read More
Bhopal: Prime Minister Narendra Modi lashed out at critics of the Mahakumbh Mela at a… Read More
This website uses cookies.
